Transaction for prized lender could cost $12bn and be announced after Thanksgiving holiday
The company, part way through a turnaround plan, says the cash and shares proposal undervalues the business
Regulator to change approach to focus on systemic risk as consolidation increases
Any evidence of consolidation would help
Spanish healthcare group had previously been object of short seller report